BRIEF-China Food and Drug Administration approves Gilead’s Sovaldi
September 25, 2017 at 08:19 AM EDT
* China Food and drug Administration approves Gilead’s Sovaldi (sofosbuvir) for treatment of chronic Hepatitis C virus infection
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.